Mouse anti-Human/Mouse/Rat sapiens (Human) FBXO22 Monoclonal Antibody

Mouse anti-Human/Mouse/Rat sapiens (Human) FBXO22 Monoclonal Antibody — Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex that is implicated in the control of various cellular processes such as cell cycle control, tra…

SKU: BCREC-000376MA Category:

Product Specifications

Uniprot No.Q8NEZ5
Target NamesFBXO22
Species ReactivityMouse
ImmunogenRecombinant Human FBXO22 protein
Immunogen SpeciesHomo sapiens (Human)
ConjugateNon-conjugated
IsotypeMouse IgG1
ClonalityMonoclonal
ApplicationsELISA, WB, FC
BufferPBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
StorageUpon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Function

Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex that is implicated in the control of various cellular processes such as cell cycle control, transcriptional regulation, DNA damage repair, and apoptosis. Promotes the proteasome-dependent degradation of key sarcomeric proteins, such as alpha-actinin (ACTN2) and filamin-C (FLNC), essential for maintenance of normal contractile function. Acts as a key regulator of histone methylation marks namely H3K9 and H3K36 methylation through the regulation of histone demethylase KDM4A protein levels.

Biological Context

Subcellular Location: Cytoplasm; Nucleus; Cytoplasm, myofibril, sarcomere, Z line
Tissue Specificity: Predominantly expressed in liver, also enriched in cardiac muscle
Disease Association: Tayoun-Maawali syndrome (TYMAS) : An autosomal recessive pleiotropic syndrome characterized by multiple abnormalities encompassing early growth restriction, neurodevelopmental delay, and craniofacial, cardiovascular, gastrointestinal, urinary and endocrine anomalies. [The disease is caused by variants affecting the gene represented in this entry]

Product Specifications

Mouse anti-Human/Mouse/Rat sapiens (Human) FBXO22 Monoclonal Antibody is a recombinant protein. Suitable for ELISA and Western Blot applications.

Applications: ELISA, WB, FC

Biological Activity: Not implied unless activity data are explicitly listed on this product page, the datasheet, or the CoA.

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Shipping & Lead Time: Availability, shipping conditions, and estimated lead time are confirmed in the formal quotation or order confirmation based on the product format, destination, and order requirements.

Protein Biology

Function

Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex that is implicated in the control of various cellular processes such as cell cycle control, transcriptional regulation, DNA damage repair, and apoptosis. Promotes the proteasome-dependent degradation of key sarcomeric proteins, such as alpha-actinin (ACTN2) and filamin-C (FLNC), essential for maintenance of normal contractile function. Acts as a key regulator of histone methylation marks namely H3K9 and H3K36 methylation through the regulation of histone demethylase KDM4A protein levels (PubMed:21768309). In complex with KDM4A, also regulates the abundance of TP53 by targeting methylated TP53 for degradation at the late senescent stage (PubMed:26868148). Under oxidative stress, promotes the ubiquitination and degradation of BACH1. Mechanistically, reactive oxygen species (ROS) covalently modify cysteine residues on the bZIP domain of BACH1, leading to its release from chromatin and making it accessible to FBXO22 (PubMed:39504958). Upon amino acid depletion, mediates 'Lys-27'-linked ubiquitination of MTOR and thereby inhibits substrate recruitment to mTORC1 (PubMed:37979583). Also inhibits SARS-CoV-2 replication by inducing NSP5 degradation (PubMed:39223933)

Subcellular Location

Cytoplasm; Nucleus; Cytoplasm, myofibril, sarcomere, Z line

Disease Association

Tayoun-Maawali syndrome (TYMAS) : An autosomal recessive pleiotropic syndrome characterized by multiple abnormalities encompassing early growth restriction, neurodevelopmental delay, and craniofacial, cardiovascular, gastrointestinal, urinary and endocrine anomalies. [The disease is caused by variants affecting the gene represented in this entry]

Tissue Specificity

Predominantly expressed in liver, also enriched in cardiac muscle

Subunit

(Microbial infection) Interacts with SARS_COV-2 protein NSP5; this interaction attenuates NSP5-mediated inhibition of innate immunity

Gene: FBXO22  |  Organism: Homo sapiens  |  Synonyms: F-box protein FBX22p44
Key Publications

Frequently Asked Questions

How do I order or inquire about this product?

Submit the Online Inquiry form with your required quantity and specifications, or email sales@biocrestsci.com. Available sizes, pricing, stock status, documentation, and estimated lead time are confirmed in the formal quotation.

What is the shipping and delivery time?

Availability, dispatch timing, shipping conditions, and delivery estimates depend on the product format, destination, and order requirements. These details are confirmed in the formal quotation or order confirmation.

How should this product be stored?

Follow the storage and handling instructions in the product-specific datasheet and Certificate of Analysis (CoA). Requirements may vary by product form and formulation; contact BioCrest Sci if product-specific guidance is needed.

What quality controls are performed on your products?

Quality-control data such as identity, purity, endotoxin level, or biological activity are provided only when specified on this product page, the datasheet, or Certificate of Analysis (CoA). Biological activity is not implied unless explicitly stated.

Shopping Cart
Scroll to Top